Doripenem in the Treatment of Complicated Intra-Abdominal Infections

• Status: Completed
• Trial end date: 2006-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the clinical response rate of doripenem versus a comparator in the treatment of hospitalized patients with complicated intra-abdominal infections.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
• Collaborator: Peninsula Pharmaceuticals, Inc.
• Treatments: Doripenem

Criteria

Inclusion Criteria:

• Has a requirement for surgical intervention within 24 hours of study entry

• Requirement of antibacterial therapy in addition to surgical intervention in certain intra-abdominal infections

Exclusion Criteria:

• Female patients who are pregnant, nursing, or if of child bearing potential not using a medically accepted, effective method of birth control

• Any rapidly-progressing disease or immediately life-threatening illness